Take a look at the Recent articles

Randomized controlled, clinical blinded study to evaluate the main cause of periodontal disease, the predominant presence of bacteria in percentage and the total bacterial load before and after non-surgical therapy

Giuseppe Grech

Aprilia LT, II level Master of Periodontology, Faculty of Medicine and Dentistry Sapienza University of Rome, Italy.

E-mail : aa

DOI: 10.15761/DOMR.1000398

Article
Article Info
Author Info
Figures & Data

Abstract

Goals: Evaluate the root cause of periodontal disease, the predominance of bacteria and the total bacterial load before and after. Materials and Methods: Microbiological Tests: it consists in taking the crevicular fluid colonized by bacteria and containing epithelial cells of the person being examined, using a sterile paper cone with a diameter of 60/80 in the periodontal or peri-implant pocket for at least 30 seconds (so that it is soaked in liquid crevicular possibly without blood); it is placed inside the test tube; the procedure is repeated to obtain from a minimum of two to a maximum of four paper cones. The test was performed on 420 patients aged 30-60 years, 236 women, 184 men, 4-11mm pockets moderate-severe chronic periodontitis, for a total of 498 samples, in 78 patients a second sampling was carried out after treatment. Results: The study highlighted that the main cause of periodontal disease are parafunctions (Bruxism, clenching, bad habits, atypical swallowing, mouth breathing), dental misalignment, pre-contacts and incongruous prosthetic products. Therefore, as "direct and triggering" local etiological factors and no longer "indirect and predisposing" as has always been claimed. In the background by bacteria.

Keywords

Periodontal disease, Inflammation, Plaque, Tartar, Bacteria, Microbiological Analysis, Parafunctions

Introduction

The periodontal disease: The term periodontal disease (periodontitis) indicates a set of inflammatory pathologies, of an infectious nature, which are characterized at a clinical level by the pathological involvement of all the tissue components of the periodontal organ (gingiva, periodontal ligament, alveolar bone and root cementum) [1-3]. “Direct and triggering” local etiological factors: Bacterial (bacterial plaque, tartar, “alba” (“dawn”) material, food residues.

“Indirect and aggravating local” factors: Functional (occlusal trauma, parafunctions, bad habits, oral respiration, atypical swallowing, hypofunction).

"Indirect and predisposing" factors: Mechanical (wrong oral hygiene, presence of food). Anatomical (dental malposition, dental shape, shape of periodontal tissues).

"Indirect, predisposing and aggravating": Iatrogenic (overflowing fillings, incorrect prosthetic margins, oversized prosthetic crowns and orthodontic devices) [4,5].

The initiation and progression of periodontal disease are commonly attributed to pathogenic bacteria of the oral microbiota, mainly part of the red/orange complexes:

Aggregatibacter actinomycetemcomitans
Porphyromonas gingivalis
Tannerella forsythia
Treponema denticola
Fusobacterium nucleatum
Campylobacter rectus

Other factors including bad habits, anatomical and latrogenic, genetic and hereditary factors.

The aim of this study is to evaluate the main cause of periodontal disease, the predominant presence of bacteria in percentage and the total bacterial load before and after non-surgical therapy [6,7].

Materials and Methods

Microbiological Tests: it consists in taking the crevicular fluid colonized by bacteria and containing epithelial cells of the person being examined, using a sterile paper cone with a diameter of 60/80 in the periodontal or peri-implant pocket for at least 30 seconds (so that it is soaked in liquid crevicular possibly without blood); it is placed inside the test tube; the procedure is repeated to obtain from a minimum of two to a maximum of four paper cones. The test was performed on 420 patients, aged 30-60 years, 236 women, 184 men, 4-11mm pockets moderate-severe chronic periodontitis, for a total of 498 samples, in 78 patients a second sampling was carried out after treatment [6-9].

The patients had received no antibiotics or periodontal treatment during the past 6 months, no systemic disease. It follows the methodology, but differs primarily in the choice of patients, with specific characteristics (age, smokers 10/20 cigarettes a day, moderate- severe periodontitis, 4/11mm periodontal pockets) more responsive to ordinary people. Plaque index (IP), bleeding index (BoP), pocket depth (PPD), mobility (M), recession (GAC) was evaluated. All patients were provided with information about the study, having signed the informed consent [10-14].

Clinical Procedures: Microbiological testing was used for the study. The mesial area of the upper right first molar (1.6) and the mesial area of the lower left first molar (3.6) were selected. A group of 78 patients underwent a second sampling after treatment. (Scaling and root planning).

Microbiological Analysis Results

The following sample was analyzed: 498 withdrawals for a total of 420 patients.

In 78 patients a second sampling was carried out after the treatment, for a consideration of 15,7% of the total samples and 18,6% of the patients.

The bacterium Aggregatibacter actinomycetemcomitans is present in 2.2% of the samplings (11 cases out of 420) with values ranging from 0,0006% to 1,7875% of the total bacterial load, with an average value of 0,4995% before treatment (Graph 1).

The bacterium Porphyromonas gingivalis is present in 25,5% of the samplings (127 cases out of 420) with values ranging from 0,0003% to 48,5433%, with an average value of 2,7917 on the total bacterial load. In the case of patients in which the measurement was made before treatment, the average percentage value is 2,8689, the average value after treatment drops to 0,4178% (Graph 2).

The Tannerella forsythia bacterium is present in 31,3% of the samplings (156 cases out of 420) with values ranging from 0,0004% to 15,1197% with an average percentage value of 1.1961 on the total bacterial load. In the case of patients in which the measurement was made before treatment, the average percentage value is 1,2331, the average value after treatment is 0,5912% (Graph 3).

The Treponema denticola bacterium is present in 32,7% of the samplings (163 cases out of 420) with values ranging from 0,0010% to 52,4201%, with an average percentage value of 1,5862 on the total bacterial load. In the case of patients in which the measurement was made before treatment, the average percentage value is 1,6668, the average value after treatment is 0,846% (Graph 4).

The Fusobacterium nucleatum bacterium is present in 72,5% of the samplings (361 cases out of 420) with values ranging from 0,0035% to 86,3505%, with an average value of 6,4628% of the total bacterial load. In the case of patients in which the measurement was made before treatment, the average percentage value is 7,0148, the average value after treatment is 2,5865 (Graph 5).

The Campylobacter rectus bacterium is present in 37,5% of the samplings (187 out of 420 cases) with values ranging from 0,0006% to 29,5476%, with an average value of 1,5387% of the total bacterial load. In the case of patients in which the measurement was made before treatment, the average percentage value is 1,4527, the average value after treatment rises to 2,4589 (Graph 6).

Discussion

The graphs have highlighted that after the treatment (Scaling and root planning) there is a drastic reduction (elimination of some bacteria) of the bacteria and of the total bacterial load. Before treatment the presence of Aggregatibacter actinomycetemcomitans, Tannerella forsythia, the percentage is very low and in many cases their absence, on the other hand we have a very high percentage of the bacterium Fusobacterium nucleatum also present in the intestine and causes colorectal cancer (studies have demonstrated a correlation between the bacterium present in the oral cavity and colorectal cancer).

In graph 6, the Parafunctions are 70% (bruxism, clenching, atypical swallowing, precontacts, bad habits, dental misalignment, oral respirator and incongruous prosthetic products), with high bacterial load in some cases without main bacteria in other cases the almost constant presence of the bacterium Fusobacterium nucleatum, out of 420 patients 263 are with parafunctions 157 periodontal disease is attributed to bacteria.

Of these 263 patients (Chart 15)
N 60 are without bacteria
N 86 are without 5 bacteria
N 112 are without the first 4 bacteria
N 2 only have Aggregatibacter actinomycetemcomitans
N 13 have only Porphyromonas gingivalis
N 173 have Fusobacterium nucleatum

Results

The study highlighted that the main cause of periodontal disease are parafunctions (bruxism, clenching, bad habits, atypical swallowing, mouth breathing), dental misalignment, pre-contacts and incongruous prosthetic products. Therefore as "direct and triggering" local etiological factors and no longer "indirect and predisposing" as has always been claimed. In the background by bacteria. Before treatment the presence of Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Tannerella forsythia, the percentage is very low and in many cases their absence, on the other hand we have a very high percentage of the bacterium Fusobacterium nucleatum, also present in the intestine and causing colorectal cancer (studies have shown a correlation of the bacterium present in the oral cavity and colorectal cancer). After the treatment (Scaling and root planning) there is a drastic reduction (elimination of some bacteria) of the bacteria and of the total bacterial load [15-26].

Out of 420 patients 263 are with parafunctions 157 periodontal disease is attributed to bacteria.
Of these 263 patients (Chart 15)
N 60 are without bacteria
N 86 are without 5 bacteria
N 112 are without the first 4 bacteria
N 2 only have Aggregatibacter actinomycetemcomitans
N 13 have only Porphyromonas gingivalis
N 173 have Fusobacterium nucleatum

Out of 78 patients where a second sampling was carried out after treatment, 40% (31 patients) of the patients had Fusobacterium nucleatum always present.

Acknowledgement: I

 thank Dr. Nicole Savioli, Dr. Laura Giuliani, the ASO manager Manuela Fuganti and all the staff of the "Dr Giuseppe Grech" team for the collaboration. I thank Dr. Caterina Giovinazzo for the technical-scientific support.

References

  1. American Academy of Periodontology (1989) Supportive treatment. In: Proceedings of the World Workshop in Clinical Periodontics: Chicago. Am Acad Periodontol 24.
  2. American Academy of Periodontology (1998) Position Paper. Supportive periodontal therapy (SPT). J Periodontol 69: 502-506. [Crossref]
  3. The American Academy of Periodontology, Position Paper (2003) Periodontal Maintenance. J Periodontol 74: 1395-1401.
  4. Löe H, Theilade E, Jensen SB (1965) Experimental gingivitis in man. J Periodontol 36: 177-187. [Crossref]
  5. Löe H, Anerud A, Boysen H, Morrison E (1986) Natural history of periodontal disease in man. Rapid, moderate, and no loss of attachment in Sri Lankan laborers 14 to 46 years of age. J Clin Periodontol 13: 431-445. [Crossref]
  6. Aass AM, Preus HR, Zambon JJ, Gjermo P (1994) Microbiologic tests in epidemiologic studies: are they reproducible? Scand J Dent Res 102: 355-360. [Crossref]
  7. Abrahamson M, Wikström M, Potempa J, Renvert S, Hall A (1997) Modification of cystatin C activity by bacterial proteinases and neutrophil elastase in periodontitis. Mol Pathol 50: 291-297. [Crossref]
  8. Abu-Amer Y, Ross FP, Edwards J, Teitelbaum SL (1997) Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J Clin Invest 100: 1557-1565. [Crossref]
  9. Addy M, Langeroudi M, Hassan H (1985) The development and clinical use of acrylic strips containing anti-microbial agents in the management of chronic periodontitis. Int Dent J 35: 124-132. [Crossref]
  10. Adriaens PA (1989) Bacterial invasion in periodontitis, is it important in periodontal treatment? Rev Belge Med Dent 44: 9-30. [Crossref]
  11. Amsterdam M, Rossman SR (1960) Technique of hemisection of multirooted teeth. Alpha Omegan 54: 4.
  12. Amsterdam M (1974) Periodontal Prosthesis: Twenty-five years in retrospect. Alpha Omegan. [Crossref]
  13. Amsterdam M (1980) Periodontal Prosthesis. In Goldman H.M. Cohen, D.W. Periodontal Therapy.
  14. Beaudreau DE (1965) The role of the posterior fixed bridge in occlusion. Dent Clin North Am 13:24. [Crossref]
  15. Beaudreau DE (1980) Periodontal considerations in restorative dentistry. In Goldman H.M., Cohen D.W., Periodontal therapy ed. 6 St. Louis: Mosby 1116.
  16. Bower RC (1979) Furcation morphology relative to periodontal treatment. J Periodontol 50: 23-27. [Crossref]
  17. Box HK (1935) Experimental traumatogenic occlusion in sheep. Oral Health 25: 9.
  18. Carnevale G, Di Febo G (1981) Greter New York Academy of Prosthodontics. Personal Commun.
  19. Carnevale G, Freni SS (1982) Ist. International Congress of the Italian Society of Periodontology. Personal Commun.
  20. Carnevale G, Freni SS, Di Febo G (1983) Soft and hard tissue wound healing following tooth preparation to the alveolar crest. Int J Periodont Rest Dent 6: 36-53. [Crossref]
  21. McIlvanna E, Linden GJ, Craig SG, Lundy FT, James JA (2021) Fusobacterium nucleatum and oral cancer: a critical review. BMC Cancer 21: 1212. [Crossref]
  22. Gallimidi AB, Fischman S, Revach B, Bulvik R, Maliutina A, et al. (2015) The periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral specific chemical carcinogenesis model. Oncotarget 6: 22613-22623. [Crossref]
  23. Fujiwara N, Kitamura N, Yoshida K, Yamamoto T, Ozaki K, et al. (2020) Involvement of Fusobacterium species in oral cancer progression: a literature review including other cancer types. Int J Mol Sci 21: 6207. [Crossref]
  24. Komiya Y, Shimomura Y, Higurashi T, Sugi Y, Arimoto J, et al. (2019) Colorectal cancer patients have identical strains of Fusobacterium nucleatum in colorectal cancer and oral cavity. Gut 68: 1335-1337. [Crossref]
  25. Abed J, Maalouf N, Manson AL, Earl AM, Parhi L, et al. (2020) Colon cancer - Associated Fusobacterium nucleatum can originate from the oral cavity and reach colon cancers via the circulatory system. Front Cell Infect Microbiol 10: 400. [Crossref]
  26. Tefiku U, Popovska M, Cana A, Zendeli-Bedxeti L, Recica B, et al. (2020) Determination of the role of Fusobacterium Nucleatum in the pathogenesis inside and outside the mouth. Pril 41: 87-99.

Editorial Information

Founding Editor-in-Chief

Shigeru Watanabe
Meikai University Japan

Editor-in-Chief

Vagner Rodrigues
Federal University of Minas Gerais

Article Type

Research Article

Publication history

Received: February 22, 2023 Accepted: March 17, 2023 Published: March 22, 2023

Copyright

©2023 Grech G. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Citation

Giuseppe Grech (2023) Randomized controlled, clinical blinded study to evaluate the main cause of periodontal disease, the predominant presence of bacteria in percentage and the total bacterial load before and after non-surgical therapy. Dent Oral Maxillofac Res 9: DOI: 10.15761/DOMR.1000398

Corresponding author

Giuseppe Grech

Aprilia LT, II level Master of Periodontology, Faculty of Medicine and Dentistry Sapienza University of Rome, Italy

Figure 1. Presence of bacteria and parafunctions in the whole sample before treatment

Figure 2. Presence of bacteria and parafunctions before treatment

Figure 3. Presence of bacteria and parafunctions after treatment

Figure 4. Presence of bacteria without parafunctions

 
 
 
 


Figure 5. Total bacterial load before treatment

Figure 6. Total bacterial load after treatment

 
 

Figure 7. Normal bacterial load distribution in parafunction before treatment

 
 

Figure 8. Normal bacterial load distribution in parafunction after treatment

Figure 9. Bacteria presence in parafunctions

(prima = 1 o dopo

= 2)

 

 

 

Codice Paziente

azione (no = 0 o si = 1)

 

 

 

M o F

 

 

 

Parafunzioni

Aggregatibacte r_actinomycete mcomitans

 

Porphyromona s_gingivalis

 

Tannerella

_forsythia

 

Treponema

_denticola

 

Fusobacterium

_nucleatum

 

Campylobacte Carica_total r_rectus  e

tinomycetemcomit ans_quantita_relati va

Porphyromonas_gi ngivalis_quantita_r elativa

 

Tannerella_forsythi a_quantita_relativa

2

Paziente 1

1

M

bruxismo

0

0

0

0

1928

2662

3277397

0,0000

0,0000

0,0000

1

Paziente 2

1

F

precontatto

0

0

0

1554

1412

0

95789

0,0000

0,0000

0,0000

1

Paziente 3

1

F

serrare

0

0

0

1554

1412

0

95789

0,0000

0,0000

0,0000

0

Paziente 4

1

F

serrare

0

0

0

0

187

0

72376

0,0000

0,0000

0,0000

0

Paziente 5

1

F

precontatto

0

0

0

2076

35883

1611

519970

0,0000

0,0000

0,0000

0

Paziente 6

1

F

serrare

0

0

0

0

2475

0

174417

0,0000

0,0000

0,0000

0

Paziente 7

1

F

precontatto

0

0

0

0

0

564

32061

0,0000

0,0000

0,0000

0

Paziente 8

1

M

bruxismo

0

0

0

0

613

580

274734

0,0000

0,0000

0,0000

0

Paziente 9

1

F

bruxismo

0

0

0

0

103

0

118676

0,0000

0,0000

0,0000

0

Paziente 10

1

 

precontatto

0

0

0

0

0

0

2435

0,0000

0,0000

0,0000

0

Paziente 11

1

F

serrare

0

0

71

0

28331

0

143417

0,0000

0,0000

0,0495

0

Paziente 12

1

F

bruxismo

0

0

0

56

0

0

120143

0,0000

0,0000

0,0000

0

Paziente 13

1

F

serrare

0

0

0

0

0

0

128673

0,0000

0,0000

0,0000

0

Paziente 14

1

M

bruxismo

0

0

0

0

4688

0

415385

0,0000

0,0000

0,0000

0

Paziente 15

1

F

precontatto

0

0

0

0

716

493

6531

0,0000

0,0000

0,0000

1

Paziente 16

1

M

precontatto

0

151

0

0

1529

1009

101658

0,0000

0,1485

0,0000

0

Paziente 17

1

M

bruxismo

0

0

0

0

1952

279

133606

0,0000

0,0000

0,0000

0

Paziente 18

1

F

precontatto

0

0

0

0

5698

159

203460

0,0000

0,0000

0,0000

0

Paziente 19

1

F

bruxismo

0

0

0

0

58

0

45088

0,0000

0,0000

0,0000

0

Paziente 20

1

F

bruxismo

0

0

0

0

1949

0

441213

0,0000

0,0000

0,0000

0

Paziente 21

1

F

bruxismo

0

0

0

92

0

0

1362868

0,0000

0,0000

0,0000

0

Paziente 22

1

F

bruxismo

0

0

0

0

1114

0

90735

0,0000

0,0000

0,0000

1

Paziente 23

1

 

precontatto

0

0

0

0

572

965

135111

0,0000

0,0000

0,0000

0

Paziente 24

1

F

precontatto

0

85

237

0

281

568

40704

0,0000

0,2088

0,5823

0

Paziente 25

1

M

bruxismo

0

0

0

0

0

0

38099

0,0000

0,0000

0,0000

0

Paziente 26

1

F

bruxismo

0

0

0

0

8985

4526

3332463

0,0000

0,0000

0,0000

0

Paziente 27

1

M

precontatto

0

0

0

0

0

0

80914

0,0000

0,0000

0,0000

0

Paziente 28

1

F

serrare

0

0

0

0

154

0

320538

0,0000

0,0000

0,0000

0

Paziente 29

1

F

precontatto

0

0

0

0

0

0

31681

0,0000

0,0000

0,0000

0

Paziente 30

1

F

serrare

0

0

0

0

0

0

62790

0,0000

0,0000

0,0000

1

Paziente 31

1

F

serrare

0

0

0

0

0

0

99420

0,0000

0,0000

0,0000

1

Paziente 32

1

M

serrare

0

0

0

0

2115

10660

14225762

0,0000

0,0000

0,0000

0

Paziente 33

1

M

bruxismo

0

0

0

0

1136

426

29388

0,0000

0,0000

0,0000

1

Paziente 34

1

F

bruxismo

0

0

0

0

0

0

4101536

0,0000

0,0000

0,0000

0

Paziente 35

1

F

serrare

0

0

0

0

0

0

4101536

0,0000

0,0000

0,0000

0

Paziente 36

1

M

serrare

0

0

0

0

1383

92

87633

0,0000

0,0000

0,0000

0

Paziente 37

1

F

serrare

0

0

0

0

4346

2505

64383

0,0000

0,0000

0,0000

1

Paziente 38

1

F

precontatto

0

0

0

0

1910

144

694984

0,0000

0,0000

0,0000

1

Paziente 39

1

F

precontatto

0

0

0

212

101371

15915

191938

0,0000

0,0000

0,0000

0

Paziente 40

1

M

precontatto

0

0

0

0

0

0

77556

0,0000

0,0000

0,0000

0

Paziente 41

1

M

bruxismo

0

0

0

0

0

0

142997

0,0000

0,0000

0,0000

Figure 10. Patient

Figure 11. Arch

 
 

Figure 12. Orthopanoramic

Figure 13. Full intraoral

Figure 14. Periodontal chart

Figure 15. Microbiological test